Click on the images and links below to see more of what Save Your Skin Foundation is talking about!

Ernst: Life and death decisions made in dark 

London Free Press, December 1, 2017

In 2012, ipilimumab, the first-generation checkpoint inhibitor, was approved and now 25 per cent of patients who have not undergone other treatment but receive ipilimumab experience long-term survival, compared with a historical survival of five to 10 per cent.  With newer therapies, pembrolizumab and nivolumab, survival is even superior to ipilimumab. They are generally used as initial treatments in metastatic melanoma. However, ipilimumab is still effective in some patients who have failed newer therapies.

So why, one year ago, did all public drug plans suddenly and without consultation with provincial experts defund ipilimumab? Canada is the only western country to defund this therapy.  To read the article click HERE

Sun Protection A Year-Round Necessity The Globe & Mail, September 25, 2017

About 10 months after she was diagnosed at 37 with melanoma, (Natalie) Richardson began volunteering for the Save Your Skin Foundation, a non-profit advocacy organization founded by Vancouver melanoma survivor Kathleen Barnard. After starting out writing blogs to connect with other survivors, Richardson became a full-time project co-ordinator last fall.

She stresses there’s no such thing as a “safe tan” or “just skin cancer,” the most commonly diagnosed form of cancer in North America. To read the full article click HERE

MacLean’s Canada 150 Special Issue: Patient Access to Medication

Louise Binder speaks in the “Patient Access to Medication” campaign launched June 14, 2017. This was published within the Maclean’s Canada 150 Special Issue to a readership of 1.4 million Canadians, and will be on newsstands for a month.

The campaign sends a powerful message to Canadians – despite being an innovative nation, many patients in Canada still struggle to access life-saving medications. By uniting industry-leading experts and patients, we are encouraging sustainable access to medication and a collaborative path forward.  To read the article click HERE

Think immunotherapy is right for you? Talk to your MP                                                                         

North Shore News, June 3, 2017                                                                

It was an innovative solution that saved Barnard after she was diagnosed with melanoma. Doctors found cancer in her left lung, kidney, liver and adrenal gland, and in 2005 she was given six months to live. As she prepares to celebrate one more National Cancer Survivors Day on Sunday, Barnard credits her survival to a clinical trial during which she was given the immunotherapy treatment Yervoy. Read more

Radio Interview: Sun Safety   CBC BC Almanac, May 24, 2017

Kathleen Barnard, President and Founder of Save Your Skin Foundation, was interviewed by Michelle Elliot on the CBC Almanac podcast. After an informative detailing of prevention and detection of melanoma and non-melanoma skin cancers with Dr. Marcie Ulmer, Dermatologist and Clinical Instructor of Dermatology at UBC, Kathy had the opportunity to discuss her experience with advanced metastatic melanoma and her subsequent treatments, side effects, and the creation of Save Your Skin Foundation.  To listen to the interview excerpt, please click HERE

together we can make a difference

Making awareness and education available is crucial. Since 2006, the Foundation has worked to raise awareness of melanoma and non-melanoma skin cancers focusing on education, prevention and the need for improved patient care.

Show Buttons
Hide Buttons